Afuco™ Anti-Human FLT4 ADCC Therapeutic Antibody (IMC-3C5), ADCC Enhanced
Anti-FLT4 ADCC Enhanced Antibody (IMC-3C5) is an ADCC enhanced antibody produced by our Afuco™ platform. IMC-3C5 is a human IgG1 monoclonal antibody receptor antagonist designed to bind VEGFR3 and block the binding of VEGF-C and VEGF-D ligands to the receptor, used to treat solid tumors.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-279CL |
| Pricing | Inquiry |
| Host | Human |
| Target | FLT4 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage. |